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Allergic contact dermatitis is one of the most frequent dermatological problems affecting 7% of the general
population. Impaired skin barrier function facilitates the penetration of contact allergens and irritants into the
epidermal layer and is regarded as an important cofactor promoting the process of allergic contact sensitization.
Filaggrin is crucial for the maintenance of the skin barrier function. Loss-of-function mutations within the
filaggrin (FLG) gene are associated with skin barrier diseases such as ichthyosis vulgaris and atopic eczema (AE).
To assess the impact of FLG on allergic contact sensitization and plausible intermediate traits, the two prevalent
FLG mutations R501X and 2282del4 were typed in 1,502 individuals of the KORA C population-based cohort with
extensive dermatologic phenotyping. Associations of FLG mutations with AE could be replicated. Strong
associations were seen with dry skin, palmar hyperlinearity, and keratosis pilaris. In addition, an association with
contact sensitization to nickel and contact sensitization to nickel combined with intolerance to fashion jewelry,
but not with other contact allergens, was observed. From these data, we conclude that a genetically determined
FLG deficiency manifests as dry skin and features of ichthyosis vulgaris. In addition, FLG deficiency may also
represent a risk factor for contact sensitization to allergens.
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INTRODUCTION
Recently, null mutations in the filaggrin (FLG) gene were
identified as the cause of ichthyosis vulgaris (Smith et al.,
2006), one of the most common disorders of keratinization.
In the meantime, FLG mutations have also been established
as strong genetic risk factors for atopic eczema (AE) (Barker
et al., 2006; Marenholz et al., 2006; Morar et al., 2007;
Palmer et al., 2006; Ruether et al., 2006; Sandilands et al.,
2006; Stemmler et al., 2006; Weidinger et al., 2006a, b).
Ichthyosis vulgaris and AE are characterized by dry and scaly
skin and show many overlapping characteristics as well as
association with each other (Okulicz and Schwartz, 2003). A
hallmark of both diseases is an impaired skin barrier with
profound changes in skin physiology such as increased
epidermal water loss, shift in pH, low hydration, and changes
in molecular composition of the stratum corneum (Cork et al.,
2006; Proksch et al., 2006).
The main function of filaggrin is to aggregate keratin
filaments leading to keratinocyte compaction and formation of
the stratum corneum (Candi et al., 2005). It is thereby crucial
for engineering and maintaining the barrier function of the skin.
Two FLG mutations, R501X and 2282del4, have been shown
to be prevalent in the white European population (Sandilands
et al., 2007), and it has been suggested that reduction or loss of
filaggrin expression leads to a disturbed barrier formation,
which manifests as varying degrees of dry skin, ichthyosis
vulgaris, and/or eczema (McLean and Hull, 2007). In addition,
it might allow an increased passage of antigens, allergens, and
chemicals through the epidermis and thereby facilitate allergic
sensitization. This would explain additional associations
observed for asthma, sensitization, and increased IgE levels in
the context of AE (Irvine and McLean, 2006). However, the
functional consequences and exact phenotypic characteristics
caused by FLG mutations are not completely understood, and
the hypothesis of a ‘‘dry or defective barrier’’ in FLG mutation
carriers remains to be proven (Irvine, 2007).
Allergic contact dermatitis (ACD) is one of the most
frequent dermatological problems affecting about 7% of the
general population (Nielsen et al., 2001; Heine et al., 2004).
The current disease model proposes that it develops based on
the interactions between genetic and environmental factors.
Some of these environmental factors have been defined as the
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nature and concentration of hapten, time and frequency of
the allergen exposure, and the status of skin damage (Bryld
et al., 2004). As haptens have to cross the horny layer of the
skin to interact with cutaneous dendritic cells, which are
capable of presenting the haptenized peptides to T cells, skin
barrier disruption plays a central role in the pathophysiology
of contact dermatitis (Proksch et al., 2006).
Here we aim to investigate the potential role of FLG
mutations in allergic contact sensitization and to work out
phenotypic characteristics of FLG mutation carriers using a
large population-based sample of adults with extensive
dermatological phenotyping, including patch testing of 25
standard allergens.
RESULTS
In this study, both FLG mutations previously identified to
result in a deficiency of filaggrin expression were genotyped
in 1,502 German adults. The clinical characteristics of the
study population are outlined in Table 1. The genotyping
success rate was 99.1% for R501X and 98.7% for 2282del4.
Observed genotype frequencies of both polymorphisms
did not deviate significantly from expected frequencies under
the Hardy–Weinberg equilibrium assumption. Geno-
types were distributed equally between male and female
individuals.
In this cross-sectional German population, the 2282del4
variant was present in 5.7% of adults and the frequency of
carriers of R501X was 2.2%, resulting in a combined carrier
frequency of 7.5% (Table 2).
Strong FLG effect on AE and stigmata of atopic constitution
independently from AE
The known association between FLG mutations and AE
could be replicated in the KORA C population. We estimated
an odds ratio (OR) of 6.78 (95% confidence interval (95% CI)
2.76–16.64) for the combined genotype. No independent
associations were seen with total IgE levels and for type 1
sensitization despite association with sensitization to cat
allergen (P¼0.031) and a trend for association with
sensitization to mite allergen (P¼ 0.060). In patients suffering
from any atopic disease (that is, allergic rhinoconjunctivitis
AE or asthma), linear regression on log-transformed IgE values
showed a strong association (P¼0.009).
FLG-null alleles showed strong associations with palmar
hyperlinearity (R501X, P¼ 3.4104; 2282del4, P¼4.3
1014; combined genotype (R501X and 2282del4), P¼7.2
1015), dry skin (2282del4, P¼1.8 105; combined
genotype, P¼ 104), and keratosis pilaris (2282del4, P¼
0.0018; combined genotype, P¼ 104). No associations were
seen with Dennie–Morgan infraorbital fold or Herthoge’s
sign.
Association of R501X and 2282del4 with contact allergy to
nickel
Data on patch tests and contact dermatitis in the KORA C
cohort have been published previously (Schafer et al., 2001).
Briefly, a total of 1,141 valid patch tests were analyzed and
40.0% of the subjects exhibited at least one positive reaction
(Table 1). For association analysis with FLG mutations, a total
of 1,133 individuals with genotype data and valid patch tests
were analyzed. No associations were seen with self-reported
adverse skin reactions to fashion jewelry, fragrances, or
occupational allergens. Analysis of the traits contact sensiti-
zation against at least one allergen and contact sensitization
against one or more allergens did not yield significant
associations. In contrast, we observed a trend toward an
association with actual patch test reactions to nickel and a
significant association with actual patch test reactions to




Male gender 1,499 738 (49.1%)
Mean age (±Std) 1,502 47.2 (13.2)
Mean total IgE (±Std) 1,480 137.6 (262.7)
Total IgE 4100 1,480 498 (33.7%)
Type 1 sensitization 1,502 747 (49.7%)
Atopic eczema 1,501 56 (3.7%)
Intermediate traits
Palmar hyperlinearity 1,358 109 (8.0%)
Dry skin 1,495 246 (16.5%)
Keratosis pilaris 1,485 178 (11.9%)
Dennie–Morgan fold 1,347 323 (24.0%)
Herthoge’s sign 1,405 284 (20.2%)
Contact sensitization and contact allergy
Valid patch test results 1,160 1,141 (98.4%)
X1 contact sensitization 1,141 448 (39.3%)
X2 contact sensitization 1,141 151 (13.2%)
Contact sensitization to nickel 1,141 149 (13.1%)
Contact sensitization






Contact allergy to fragrance mix 1,141 36 (3.2%)
Table 2. Frequency of filaggrin-null alleles R501X and
2282del4 in KORA C
R501X 2282del4 Combined genotype
AA 1,455 (96.9%) 1,397 (93.0%) 1,354 (90.2%)
Aa 33 (2.2%) 85 (5.7%) 112 (7.5%)
aa — — 2 (0.1%)
www.jidonline.org 1431
N Novak et al.
Filaggrin Gene and Allergic Contact Sensitizations
nickel combined with reported intolerance to fashion jewelry
(OR¼4.04, 95% CI¼ 1.35–12.06, P¼0.0125) (Table 3).
When the analysis was restricted to women only, the
genotype effect was significantly stronger (OR¼5.49; 95%
CI¼1.63–18.45, P¼0.006) (Table 3).
DISCUSSION
Genetic modifications in EDC genes have been shown to be
associated with a deficient skin barrier as seen in chronic
eczematous skin diseases such as AE. On the basis of these
findings, the question whether genetic modifications deter-
mining for dry skin and disturbed skin barrier function might
also predispose to the manifestation of other chronic
eczematous skin diseases needs to be addressed. In this
study, we observed a slight association of the loss-of-function
mutations R501X and 2282del4 in the FLG gene with clinical
manifest sensitization against nickel(II) sulfate evaluated by
patch testing, and a more pronounced association with
positive patch testing for nickel in combination with a history
of adverse skin reactions to jewelry. In contrast, no
associations were seen with contact sensitizations to other
allergens.
The impact of a particular genetic predisposition on the
manifestation of allergic contact sensitizations is still contro-
versially discussed. Results of twin studies provided some
evidence for a genetic predisposition (Moss et al., 1985).
Furthermore, based on the observation of a strong upregula-
tion of IL-16, which induces chemotactic responses of CD4þ
T cells in delayed-type hypersensitivity reactions in animal
models (Yoshimoto et al., 2000), the association of ACD with
a promoter polymorphism in the IL16 gene has been shown
in a case–control study (Reich et al., 2003). In addition,
association of a polymorphism in the gene region encoding
for N-acetyltransferase, an enzyme that catalyzes the local
metabolization of the arylamine p-phenylenediamine, one of
the most potent contact sensitizers, with ACD has been
shown (Westphal et al., 2000a, b; Nacak et al., 2006). In this
context, for a subcollective of older female patients,
association of a polymorphism in the gene region encoding
manganese superoxide dismutase (MnSOD), one of the most
important antioxidant enzymes within the skin, with ACD has
been described (Brans et al., 2005; Yasui and Baba, 2006). In
contrast, other studies strongly support the hypothesis that
environmental influences represent the major risk factors
affecting the manifestation of ACD (Bryld et al., 2004).
Interestingly, in our cohort, the observed association between
nickel contact allergy and FLG null alleles was strikingly
stronger when analysis was restricted to female study
participants only. It seems plausible that, in female FLG
mutation carriers, a more frequent nickel exposure contri-
butes to the manifestation of contact allergy. In view of the
results of these studies and combined with our findings, it
might be speculated that the development of hyperreactivity
to some contact sensitizers is promoted by a genetic
predisposition, whereas other sensitizations will develop in
response to environmental factors alone.
We were able to show that, independently from the
presence of manifest AE, FLG mutations are strongly
associated with dry skin, palmar hyperlinearity, and keratosis
pilaris, which are all related to low hydration of the skin and
specific skin composition. It would be interesting to study
further which factors might determine the manifestation of
atopic skin disease in patients with a genetically impaired
skin barrier function. In contrast, total IgE levels were
Table 3. Results of association analysis
R501X 2282del4 Combined genotype
Phenotype OR 95% CI P-value OR 95% CI P-value OR 95% CI P-value
Atopic eczema 6.25 1.55 25.22 0.0100 4.86 1.77 13.33 0.0021 6.78 2.76 16.64 3.0 105
Palmar hyperlinearity 5.26 2.35 11.79 3.4 104 8.87 5.31 14.80 4.3 1014 7.89 4.91 12.69 7.2 1015
Dry skin 0.69 0.16 3.05 NS 3.66 2.02 6.63 1.8105 2.95 1.70 5.11 0.0001
Keratosis pilaris 2.04 0.73 5.74 NS 2.74 1.46 5.15 0.0018 2.72 1.56 4.75 0.0004
Dennie–Morgan fold 1.45 0.46 4.56 NS 0.88 0.45 1.77 NS 0.96 0.52 1.74 NS
Herthoge’s sign 0.60 0.12 3.08 NS 0.80 0.35 1.81 NS 0.66 0.31 1.42 NS
Contact sensitization to X1 contact allergen 1.14 0.45 2.90 NS 1.09 0.60 1.98 NS 1.11 0.66 1.86 NS
Contact sensitization to X2 contact allergens 0.44 0.06 3.34 NS 1.01 0.39 2.65 NS 0.88 0.37 2.11 NS
Contact sensitization to nickel 1.33 0.34 5.15 NS 2.36 1.03 5.44 0.043 1.91 0.91 4.04 NS
Contact sensitization to nickel and intolerance
of fashion jewelry
1.44 0.25 8.27 NS 5.96 1.53 23.30 0.010 4.04 1.35 12.06 0.0125
Contact sensitization to nickel and intolerance
to fashion jewelry (women only)
1.64 0.26 10.49 NS 7.83 1.72 35.76 0.0079 5.49 1.63 18.45 0.0060
Contact sensitization to fragrance mix 1.63 0.50 5.36 NS 0.46 0.14 1.55 NS 0.89 0.38 2.06 NS
Contact sensitization to fragrance mix and
intolerance of fragrances
2.57 0.50 14.44 NS 0 0 N NS 0.80 0.17 3.72 NS
NS, not significant.
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associated with FLG-null alleles in the presence of atopic
diseases only.
Nickel is the most frequent cause of hypersensitivity in the
general population (Hostynek, 2006). The induction and
elicitation of nickel contact allergy is dependent on the
amount of nickel per skin unit area present in the epidermis
(Menne et al., 1987; Fischer et al., 2007). It might be
speculated whether the disturbed skin barrier due to filaggrin
deficiency enlarges the amount of nickel in the epidermis and
thereby in particular predisposes to sensitizations to nickel,
but not to other contact allergens tested in this study.
Conversely, it has to be considered that nickel hypersensi-
tivity might be expected to be less dependent on stratum
corneum barrier integrity because the barrier is often violated
by piercing. It is of note that the association of FLG mutations
with nickel allergy described here was not related to a higher
prevalence of nickel sensitizations in atopic individuals
(Heine et al., 2004; Spiewak, 2005) as a kind of secondary
effect but occurred with the same frequency in nickel-
sensitized individuals without atopy. An important question
that arises from this data is whether people with barrier
defects have an increased rate of allergic contact sensitivity to
haptens in general.
It has to be considered that the association with nickel
contact allergy, but not with sensitization to other contact
allergens observed here might be due to different case
numbers and therefore different study power, as the group of
nickel-sensitized patients in our collective presented one of
the largest subgroups. However, we suggest that a genetically
determined skin barrier deficiency might confer an increased
risk of developing allergic contact sensitization depending on
the type of the contact allergen and sites and magnitude of
exposure. Thus, a reduced level of filaggrin caused by a
genetic predisposition might be more relevant in areas of
constitutively lower filaggrin expression, for certain allergens
and in individuals with high exposure.
However, the data presented here only give a first hint that
patients suffering from filaggrin deficiency might also be at an
increased risk for allergic sensitization against nickel. This
hypothesis still needs further evaluation and confirmation in
additional studies.
Taken together, our data on intermediate traits such as skin
dryness, aid in narrowing down the phenotype associated
with FLG-null alleles, and the preliminary data on the
association of loss-of-function mutation in the FLG gene with
specific contact sensitization shed some light on possible
further consequences of filaggrin deficiency in ACD.
MATERIALS AND METHODS
Study population
The population-based study platform KORA (‘‘Study Platform for
Cooperative Health Research in the Region of Augsburg;’’ http://
www.gsf.de/KORAN/en) and the KORA C Allergy Study have been
described in detail previously (Schafer et al., 2001; Weidinger et al.,
2004). Briefly, the ‘‘KORA Allergy Study’’ is based on a random,
cross-sectional sample stratified for age and sex studied in 1994/
1995 (n¼ 4,356) (Table 1). This study was approved by the
Ethics Committee of the Bavarian Medical Association (Bayerische
Landesa¨rztekammer) and the Bavarian commissioner for data
protection and privacy (Bayerischer Datenschutzbeauftragter) and
was performed in adherence to the Declaration of Helsinki
Principles. Consent was obtained from all patients. In the sera of
these subjects, specific IgE antibodies to timothy grass and birch
pollen, cat, cladosporium herbarum, and house dust mite (Derma-
Dermatophagoides pteronyssinus) were measured using the Phar-
macia CAP-FEIA System (Pharmacia Diagnostics, Uppsala, Sweden).
Results for specific IgE antibodies were considered positive if they
exceeded the detection limit of 0.35 kU/l. For KORA C, we aimed to
recruit an enriched sample of 1,600 subjects out of the 4,178
individuals who had valid IgE results. Subjects were selected,
stratified by age and sex, so as to provide 50% with and 50% without
specific IgE to at least one of the allergens tested, and, furthermore,
so that within these groups 50% had reported symptoms of atopic
diseases such as allergic rhinoconjunctivitis, asthma, or AE. Finally,
1,537 subjects participated, with DNA samples available from 1,502
subjects. All subjects received a full dermatologic examination by
physicians of the Department of Dermatology and Allergy, Technical
University Munich. In addition, all subjects received a conventional
lancet skin prick test and total as well as specific IgE measurements
(enzyme immunoassay: CAP-FEIA; Pharmacia Diagnostics) using a
more detailed sample of common allergens (grass, birch, rye,
mugwort pollen, Alternaria, Cladosporium, cat, dog, and Dermato-
phagoides pteronyssinus). Patch tests using a standard panel of 25
allergens (Hermal Kurt Hermann GmbH & Co, Reinbeck, Germany)
were performed as recommended by the International Contact
Dermatitis Research Group (ICDRG) and described by Schafer et al.
(2001) with reading after 72 hours. Subjects were asked whether they
had experienced adverse skin reactions to certain products, and, if
so, whether they could link these to specific things such as fashion
jewelry or fragrances (results are shown in the Table S1).
Phenotype definitions
Actual cases of AE were diagnosed using the UK diagnostic criteria
(Williams et al., 1994). Subjects were classified as suffering from
asthma or allergic rhinoconjunctivitis if they reported a physician’s
diagnosis of asthma or allergic rhinoconjunctivitis. Specific sensiti-
zation was defined to be present if at least one of the specific IgE
antibodies was positive (CAP RAST class X1, corresponding to
X0.35 kU/l). In addition, specific and total IgE values were analyzed
quantitatively.
Features of ichthyosis vulgaris and intermediate traits such as
dry skin, hyperlinearity of palms and soles, keratosis pilaris,
Dennie–Morgan infraorbital fold, and Herthoge’s sign were identi-
fied on a clinical basis, graded using a 4-point scale (0, none;
1, mild; 2, moderate; 3, severe) and considered to be present if
graded 2–3.
Valid patch tests were available from 1,141 individuals. Only
definitive positive (þ ); (þ þ ); (þ þ þ ) and negative (0) results
were considered, whereas irritative and questionable (þ /?) results
were excluded. Association analysis with the following traits was
performed: (a) monosensitized (contact sensitization to 1 of the
contact allergens tested, including nickel), (b) polysensitized
(contact sensitiziation to 41 contact allergens), and (c) sensitized
against nickel-(II) sulfate. In addition, ‘‘contact sensitization to nickel
and intolerance of fashion jewelry’’ was defined as history of
intolerance of fashion jewelry with actual patch reactions to nickel
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and ‘‘contact allergy to fragrances’’ as history of intolerance of
fragrances and actual reactions to fragrance mix.
Genotyping
Genotyping for R501X and 2282del4 was performed using the
MassARRAY system (Sequenom, San Diego, CA) as described
previously (Weidinger et al., 2006a). Briefly, genomic DNA was
amplified by PCR using HotStarTaq DNA Polymerase (Qiagen,
Hilden, Germany). The genotyping assay was carried out by using
5 ng of genomic DNA. PCR primers were used at 167 nM final
concentrations for a PCR volume of 6 ml. The PCR condition was
95 1C for 15minutes for hot start, followed by denaturing at 95 1C for
30 seconds, annealing at 56 1C for 30 seconds, extension at 72 1C
for 1minute for 45 cycles, and finally incubation at 72 1C for
10minutes. PCR products were first treated with shrimp alkaline
phosphatase (Amersham, Freiburg, Germany) for 20minutes at 37 1C
to remove excess dNTPs and afterward for 10minutes at 85 1C to
inactivate shrimp alkaline phosphatase. Thermo Sequenase (Amer-
sham) was used for the base extension reactions. Extension primers
were used at a final concentration of 5.4 mM in 10ml reactions
(Table 1). The base extension reaction condition was 94 1C for
2minutes, followed by 94 1C for 5 seconds, 52 1C for 5 seconds, and
72 1C for 5 seconds for 40 cycles. All reactions (PCR amplification,
base extension) were carried out in a Tetrad PCR thermal cycler (MJ
Research, Waltham, MA). The final base extension products were
treated with SpectroCLEAN resin (Sequenom) to remove salts in the
reaction buffer. This step was carried out with a Multimek 96-
channel autopipette (Beckman Coulter, Furllerton, CA), and 16 ml of
resin–water suspension was added into each base extension reaction,
making the total volume 26 ml. After a quick centrifugation
(2,000 r.p.m., 3minutes) in an Eppendorf Centrifuge 5810, 10 nl of
reaction solution was dispensed onto a 384 format SpectroCHIP
(Sequenom) prespotted with a matrix of 3-hydroxypicolinic acid by
using a SpectroPoint nanodispenser (Sequenom). A modified Bruker
Biflex matrix-assisted laser desorption ionization time-of-flight mass
spectrometer (Sequenom) was used for data acquisition from the
SpectroCHIP. Genotyping calls were made in real time with
MASSARRAY RT software (Sequenom).
Statistical analysis
Patch test results have been kept blinded from the genotype results.
Descriptive statistics for quantitative and qualitative values are given
by mean±SD and relative frequencies or absolute numbers,
respectively. Deviation from the Hardy–Weinberg equilibrium was
tested with PROC ALLELE in SAS/Genetics for both FLG-null
mutations. To test for associations with binary traits, logistic
regression models were applied with age, sex, and genotype as
independent variables. In addition, associations with IgE levels were
evaluated using a linear regression model on log-transformed IgE
values with the same covariates. Backward variable selection was
applied for both regression analysis. Results are given for the
estimates of genotype effects after variable selection. The P-values
are two-sided and subject to a significance level of 0.05. ORs are
given with 95% CIs and two-sided P-values in parentheses. For all
analyses, SAS statistical software package version 9.1 was used.
As shown previously (Smith et al., 2006; Sandilands et al., 2007),
the mutations are in trans- and biochemically equivalent. Therefore,
in addition, a combined genotype can be analyzed, where AA
designates homozygous wild type for FLG-null variant, Aa hetero-
zygous for either of the common FLG-null alleles R501X or
2282del4, and aa homozygous or compound heterozygous for the
FLG-null alleles R501X or 2282del4. Thus, ‘‘combined genotype’’
analyzed in this study means that both prevalent FLG mutations are
taken into account.
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SUPPLEMENTARY MATERIAL
Table S1. Frequency of positive patch test results in 1,141 adults by allergen
and gender (Schafer et al., 2001); * in petrolatum if not given otherwise.
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